top of page

TO OUR SENATORS AND REPRESENTATIVES IN WASHINGTON : 

 

I am writing to share my concerns about the serious harm that is being done to Maine’s medical cannabis industry due to the reckless and legally dubious rescheduling order from Todd Blanche, issued APRIL 28th 2026 which gave operators a deadline of 60 days to register their businesses with the DEA. There is little certainty as to the terms of signing up, what it means for businesses, what compliance looks like or what may constitute an approval or denial.  All of this has proceeded without congressional oversight, effectively asking state operators to sign an agreement without making available any of the terms and requiring a non-refundable application fee.

 Maine’s medical program is made up of over 1500 small operators, who are limited to a very small growing space, and who serve over 112,000 registered patients, nearly 8% of Maine's population. Being regulated as manufacturers and distributors of a schedule III substance requires a significant increase in operating cost that these small cottage scale businesses are not prepared to take on. This is causing a disruption in access to medicine to patients who have worked with these small caregivers for many years and built a relationship with growers they trust. 

​

This has proceeded without collaboration with state program regulators, and has created chaos, fear and confusion for operators. 

​

On Friday October 30th, the DEA issued guidance warning applicants that they may no longer do business with operators who had not applied by the June 26th deadline. Only about 10-20% of operators choose to register during the 60 day window. This has caused a split market, created supply chain issues for both those who did and did not register with the DEA and has put many operators in danger of losing their businesses. 

 

I am asking for you to ensure that the federal budget rider (SEC 531) that since 2014 has protected against federal interference in state regulated cannabis programs, which is set to expire Dec11th 2026, is extended into the future to provide stability and certainty for patients, operators and their employees. We also ask that you support efforts to DESCHEDULE this plant from the CSA so that states can administer regulations as they see fit without threats from Washington which can cause great harm to an industry that provides necessary healthcare and tax revenue to the state of Maine.

 

Thank you for your consideration of this issue and for your service to the people of Maine. 

 

CONTACTS FOR MAINE SENATORS AND REPRESENTATIVES IN CONGRESS: 

EMAIL SENATOR SUSAN COLLINS or call her office (202) 224-2523

EMAIL SENATOR ANGUS KING or call his office (202) 224-5344

EMAIL REPRESENTATIVE CHELLIE PINGREE or call her office (202) 225-6116

EMAIL REPRESENTATIVE JARED GOLDEN or call his office (202) 225-6306

bottom of page